Telix Pharmaceuticals Statistics
Total Valuation
ASX:TLX has a market cap or net worth of AUD 9.93 billion. The enterprise value is 9.80 billion.
Market Cap | 9.93B |
Enterprise Value | 9.80B |
Important Dates
The last earnings date was Wednesday, February 19, 2025.
Earnings Date | Feb 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASX:TLX has 329.55 million shares outstanding. The number of shares has increased by 6.66% in one year.
Current Share Class | n/a |
Shares Outstanding | 329.55M |
Shares Change (YoY) | +6.66% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 15.76% |
Owned by Institutions (%) | 23.38% |
Float | 284.92M |
Valuation Ratios
The trailing PE ratio is 208.30 and the forward PE ratio is 100.40. ASX:TLX's PEG ratio is 0.73.
PE Ratio | 208.30 |
Forward PE | 100.40 |
PS Ratio | 12.74 |
PB Ratio | 17.75 |
P/TBV Ratio | 65.27 |
P/FCF Ratio | 696.66 |
P/OCF Ratio | n/a |
PEG Ratio | 0.73 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 108.68, with an EV/FCF ratio of 687.61.
EV / Earnings | 196.26 |
EV / Sales | 12.51 |
EV / EBITDA | 108.68 |
EV / EBIT | 119.29 |
EV / FCF | 687.61 |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 1.02.
Current Ratio | 2.78 |
Quick Ratio | 2.57 |
Debt / Equity | 1.02 |
Debt / EBITDA | 6.45 |
Debt / FCF | 40.81 |
Interest Coverage | 2.22 |
Financial Efficiency
Return on equity (ROE) is 13.92% and return on invested capital (ROIC) is 7.80%.
Return on Equity (ROE) | 13.92% |
Return on Assets (ROA) | 5.36% |
Return on Invested Capital (ROIC) | 7.80% |
Return on Capital Employed (ROCE) | 6.93% |
Revenue Per Employee | 1.85M |
Profits Per Employee | 118,012 |
Employee Count | 234 |
Asset Turnover | 0.82 |
Inventory Turnover | 9.87 |
Taxes
Income Tax | -2.12M |
Effective Tax Rate | -68.80% |
Stock Price Statistics
The stock price has increased by +166.08% in the last 52 weeks. The beta is 2.41, so ASX:TLX's price volatility has been higher than the market average.
Beta (5Y) | 2.41 |
52-Week Price Change | +166.08% |
50-Day Moving Average | 26.28 |
200-Day Moving Average | 21.25 |
Relative Strength Index (RSI) | 67.43 |
Average Volume (20 Days) | 1,190,583 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:TLX had revenue of AUD 783.21 million and earned 49.92 million in profits. Earnings per share was 0.14.
Revenue | 783.21M |
Gross Profit | 509.68M |
Operating Income | 82.13M |
Pretax Income | 56.06M |
Net Income | 49.92M |
EBITDA | 90.15M |
EBIT | 82.13M |
Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 710.35 million in cash and 581.45 million in debt, giving a net cash position of 128.90 million or 0.39 per share.
Cash & Cash Equivalents | 710.35M |
Total Debt | 581.45M |
Net Cash | 128.90M |
Net Cash Per Share | 0.39 |
Equity (Book Value) | 568.21M |
Book Value Per Share | 1.70 |
Working Capital | 587.65M |
Cash Flow
In the last 12 months, operating cash flow was 43.03 million and capital expenditures -28.78 million, giving a free cash flow of 14.25 million.
Operating Cash Flow | 43.03M |
Capital Expenditures | -28.78M |
Free Cash Flow | 14.25M |
FCF Per Share | 0.04 |
Margins
Gross margin is 65.08%, with operating and profit margins of 10.49% and 6.37%.
Gross Margin | 65.08% |
Operating Margin | 10.49% |
Pretax Margin | 7.16% |
Profit Margin | 6.37% |
EBITDA Margin | 11.51% |
EBIT Margin | 10.49% |
FCF Margin | 1.82% |
Dividends & Yields
ASX:TLX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.66% |
Shareholder Yield | -6.66% |
Earnings Yield | 0.50% |
FCF Yield | 0.14% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 6 |